Cannara Biotech Inc. (LOVE.TO) Financials

LOVE.TO Assets vs Liabilities
DateAssetsLiabilities
Feb. 28, 2026 181.8 million 61.6 million
Nov. 30, 2025 173.8 million 62.6 million
Aug. 31, 2025 168.6 million 66.4 million
May 31, 2025 170.1 million 71.5 million

LOVE.TO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Feb. 28, 2026 -286297 1.1 million
Nov. 30, 2025 2.8 million 1.7 million
Aug. 31, 2025 1.4 million 313951
May 31, 2025 11.7 million 262772

LOVE.TO Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Feb. 28, 2026 1.7 million
Nov. 30, 2025 1.0 million
Aug. 31, 2025 3.3 million
May 31, 2025 4.1 million

LOVE.TO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Feb. 28, 2026 - - 246849
Nov. 30, 2025 16.5 million 25.7 million 322579
Aug. 31, 2025 14.4 million 28.2 million 395962
May 31, 2025 14.4 million 34.0 million 468948

LOVE.TO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Feb. 28, 2026 95.8 million
Nov. 30, 2025 96.2 million
Aug. 31, 2025 93.4 million
May 31, 2025 92.6 million

LOVE.TO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Feb. 28, 2026 3.2 million 400695 7.6 million -
Nov. 30, 2025 4.6 million 287449 8.0 million 2.7 million
Aug. 31, 2025 1.5 million 191153 6.3 million 2.7 million
May 31, 2025 2.2 million 176944 5.7 million 2.6 million

LOVE.TO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Feb. 28, 2026 27.2 million 15.5 million
Nov. 30, 2025 30.1 million 24.0 million
Aug. 31, 2025 28.6 million 16.1 million
May 31, 2025 27.3 million 14.5 million

LOVE.TO

Price: CA$1.68

52 week price:
1.06
2.07

Earnings Per Share: 0.11 CAD

P/E Ratio: 16.18

Exchange: TOR

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 175.8 million

Links: